A PHASE III SINGLE-ARM STUDY OF A NEW 13.5 MG LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM IN POSTMENARCHEAL ADOLESCENTS: AN EVALUATION OF EFFICACY, BLEEDING, USER SATISFACTION, AND PLACEMENT.

被引：2

作者：

Gemzell-Danielsson, K. ^{[1
]}

Dermout, S. ^{[2
]}

Lukkari-Lax, E. ^{[3
]}

Montegriffo, E. ^{[4
]}

Rybowski, S. ^{[5
]}

Apter, D. ^{[6
]}

机构：

[1] Karolinska Inst, Stockholm, Sweden

[2] Gynaecol Ctr Dermout & Albicher, Alkmaar, Netherlands

[3] Bayer Oy, Espoo, Finland

[4] Bayer HealthCare, Newbury, Berks, England

[5] Bayer HealthCare, Whippany, NJ USA

[6] Sexual Hlth Clin, Vaestoliitto, Finland

来源：

FERTILITY AND STERILITY | 2014年 / 102卷 / 03期

关键词：

D O I：

10.1016/j.fertnstert.2014.07.484

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

P-3

引用

页码：E141 / E142

页数：2

共 14 条

[1] A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg) in postmenarcheal adolescents
Gemzell-Danielsson, Kristina
Buhling, Kai J.
Dermout, Sylvia M.
Lukkari-Lax, Eeva
Montegriffo, Elaine
Apter, Dan
CONTRACEPTION, 2016, 93 (06) : 507 - 512
[2] A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY EXPLORING THE SAFETY OF A NEW 13.5 MG TOTAL DOSE LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM IN POSTMENARCHEAL ADOLESCENTS.
Gemzell-Danielsson, K.
Buhling, K.
Lukkari-Lax, E.
Montegriffo, E.
Rybowski, S.
Apter, D.
FERTILITY AND STERILITY, 2014, 102 (03) : E12 - E13
[3] A 12-MONTH, PHASE III STUDY OF A LOW-DOSE LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM (LNG-IUS13.5MG) IN POSTMENARCHEAL ADOLESCENTS: AN EVALUATION OF PLACEMENT EASE AND PAIN, BLEEDING AND DYSMENORRHEA
Faustmann, T.
Apter, D.
Lukkari-Lax, E.
Montegriffo, E.
Gemzell-Danielsson, K.
FERTILITY AND STERILITY, 2015, 104 (03) : E39 - E39
[4] A RANDOMIZED PHASE III STUDY COMPARING A NEW 13.5 MG LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM WITH A COMBINED ORAL CONTRACEPTIVE: ANALYSIS OF EFFICACY AND BLEEDING PROFILES.
Borgatta, L.
Roth, K.
Reowski, S.
Rosen, K.
FERTILITY AND STERILITY, 2014, 102 (03) : E143 - E143
[5] A MULTICENTER, RANDOMIZED PHASE III STUDY COMPARING A 13.5 MG LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM WITH A COMBINED ORAL CONTRACEPTIVE: ANALYSIS OF USER SATISFACTION AND SAFETY.
Borgatta, L.
Roth, K.
Rybowski, S.
Rosen, K.
FERTILITY AND STERILITY, 2014, 102 (03) : E12 - E12
[6] A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population
Fan, Guangsheng
Kang, Sukho
Ren, Mulan
Weisberg, Edith
Lukkari-Lax, Eeva
Roth, Katrin
Shin, SoYoung
CONTRACEPTION, 2017, 95 (04) : 371 - 377
[7] PHASE III STUDY OF A NEW, LOW-DOSE LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM (LNG-IUS19.5MG) OVER 5 YEARS OF USE: EVALUATION OF BLEEDING AND DYSMENORRHEA.
Faustmann, T.
Nelson, A.
Rosen, K.
Schmelter, T.
Apter, D.
FERTILITY AND STERILITY, 2015, 104 (03) : E232 - E232
[8] A 12-MONTH MULTICENTER, RANDOMIZED PHASE III STUDY COMPARING A 13.5 MG LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM WITH THE ETONOGESTREL SUBDERMAL CONTRACEPTIVE IMPLANT IN WOMEN AGED 18-35 YEARS.
Tuppurainen, M.
Lukkari-lax, E.
Grunert, J.
Rybowski, S.
FERTILITY AND STERILITY, 2014, 102 (03) : E142 - E142
[9] USER SATISFACTION, EASE OF PLACEMENT, AND DISCOMFORT DURING PLACEMENT OF TWO LOW-DOSE LEVONORGESTREL CONTRACEPTIVE INTRAUTERINE SYSTEMS (LNG-IUS) IN A MULTICENTER, RANDOMIZED, PHASE 3 STUDY
Nelson, A. L.
Danielsson, K. Gemzell
Borgatta, L.
Hauck, B.
Lynen, R.
Rosen, K.
FERTILITY AND STERILITY, 2012, 98 (03) : S194 - S194
[10] Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study
Khalighi, Misha
Wheeler, Allison P.
Adeyemi-Fowode, Oluyemisi A.
Kouides, Peter A.
Durazo-Arvizu, Ramon A.
Haley, Kristina
Dersch, Candice M.
Weyand, Angela C.
Baldwin, Maureen K.
Borzutzky, Claudia
JOURNAL OF ADOLESCENT HEALTH, 2022, 71 (02) : 204 - 209

← 1 2 →